ABCG2 and neoplasm: By contrast, we can see from the results of evaluating the stromal and immune scores in KIRC samples, ABCG2 expression significantly shows an opposite tendency, suggesting that ABCG2 plays a role in the KIRC tumor microenvironment and can be used as a therapeutic target to aid drug sensitivity.